Status:
COMPLETED
Development of an Empowerment Intervention for Young Women Living With HIV
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Conditions:
HIV
Eligibility:
FEMALE
16-24 years
Phase:
PHASE2
Brief Summary
This study will develop/adapt a culturally appropriate secondary prevention intervention for young, Human Immunodeficiency Virus (HIV)-positive women through intervention groups, evaluate its acceptab...
Eligibility Criteria
Inclusion
- Female at birth and currently female;
- Receives services at one of the selected ATN sites or their community partners
- HIV-infected as documented by medical record review or verbal verification with referring professional
- Between the ages of 16-24 years (inclusive) at the time of informed consent/assent
- Ability to understand both written and spoken English
- Gives informed consent/assent for study participation
Exclusion
- Presence of active, serious psychiatric symptoms (e.g., hallucinations, thought disorder) that would impair a participant's ability to meet the study requirements
- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior)
- Intoxicated or under the influence of alcohol or other substances at the time of study enrollment\*.
- Intoxication at the time of visit will exclude participation at that time. Participants cannot be visibly under the influence of substances at the time of enrollment or consent. If a participant returns to enroll while sober, enrollment can occur. Similarly, if a participant arrives to an intervention group visibly intoxicated, then she will be asked to leave. However, prior intoxication does not eliminate future participation. Thus, those who are dismissed from a session due to intoxication can return to a subsequent session as long as they are sober.
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT01454921
Start Date
February 1 2010
End Date
October 1 2011
Last Update
February 28 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
USF College of Medicine
Tampa, Florida, United States, 33606
2
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital
Chicago, Illinois, United States, 60612
3
University of Maryland Medical School
Baltimore, Maryland, United States, 20723